Malawi Health Donor Group Commends Ministry for Joint Annual Review on Health and HIV
During the opening of the review, Susanne Melt, Deputy Head of Cooperation at Germany Development Cooperation, highlighted significant strides made by the Ministry of Health.
LILONGWE, Malawi—The health donor group in Malawi has expressed its appreciation for the Ministry of Health and the National AIDS Commission (NAC) for organising the 2023-2024 Joint Annual Review of the Health Sector and National Response to HIV and AIDS, writes Wendi Mkandawire.
This year's review, held on November 6, 2024, is themed "Achieving Universal Health Coverage Through Integrated Health Care Models and Sustained Community Health Management in Malawi," aligning with the country's vision, Malawi 2023.
During the opening of the review, Susanne Melt, Deputy Head of Cooperation at Germany Development Cooperation, highlighted significant strides made by the Ministry of Health.
She noted that the ministry has successfully integrated contributions from the top ten donors within the health sector into a unified plan and budget aimed at realising its Health Sector Strategic Plan (HSSP) III and annual health priorities.
"Development partners assembled in the health donor group are ready to continue supporting the process of developing joint annual plans and budgets transparently at both national and district levels," Melt stated.
Secretary for Health Dr Samson Mndolo emphasised the importance of the HSSP, a medium-term strategic plan comprising nine pillars focused on enhancing the quality of healthcare services.
These pillars include improving health infrastructure and medical equipment, increasing the availability of human resources for health, and enhancing financial resources.
Dr Mndolo also extended his gratitude to the Global Fund, the World Health Organisation (WHO), and all other partners who have provided financial and technical support for the event.
He reiterated the ministry's commitment to ending HIV and AIDS, aiming to achieve the targets of 95-95-95, which represent the goals of diagnosing 95% of those infected, treating 95% of those diagnosed, and achieving viral suppression in 95% of those treated.